Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (7.961.521 €): Klimawandel und Luftverschmutzung: Künstliche Intelligenz zum Zusammenhang zwischen Luftschadstoffen und nichtübertragbaren Atemwegserkrankungen in Europa Hor 12.12.2024 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Klimawandel und Luftverschmutzung: Künstliche Intelligenz zum Zusammenhang zwischen Luftschadstoffen und nichtübertragbaren Atemwegserkrankungen in Europa
The ClimAIr project will expand the evidence-based understanding of climate change, air pollution, and non-communicable respiratory diseases by using Artificial Intelligence (AI) tools. It will gather data on greenhouse gases levels and disaster risks, information on serious air pollutants and respiratory diseases' prevalence. The AI-powered tools will be employed to generate better intervention methods and improve public health outcomes. Federated Learning (FL) will be used to develop AI models to protect patients' privacy. By raising public awareness and delivering the ClimAIr tool – specifically designed to health workers, urban planners and policy makers - the project aims to influence policy decisions, promote healthier environments, and reduce respiratory diseases in Europe, which will be tested and validated the ClimAIr tool in specific municipalities that are part of the project. ClimAIr draws on a consortium of 21 partners from 15 European countries, including carefully selected health centres across Europe – in Spain, Luxembourg, Ukraine, Italy, France, Germany, Greece, Romania and Poland – focused on respiratory diseases, which will provide disease data and explore metabolic routes of the studied contaminants/diseases. ClimAIr is composed of an interdisciplinary team formed by research centres, ethical AI and modelling experts, SSH specialists, municipal governance, and a Communication & Dissemination (C&D) expert team dedicated to achieving and spread the results of the project.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| European Academy of Allergy and Clinical Immunology | ? |
| Aristotelio Panepistimio Thessalonikis | 251.250 € |
| Asociatia Euro Atlantic Diplomacy Society | 201.963 € |
| Bukovinian State Medical University | 213.476 € |
| Centre Hospitalier Universitaire de Toulouse | 311.406 € |
| Charite - Universitaetsmedizin Berlin | 251.625 € |
| Comune Di Genova | 200.000 € |
| DCS Computing GmbH | 552.344 € |
| Fondazione Irccs CA' Granda - Ospedale Maggiore Policlinico | 0,00 € |
| Fundacion para La Investigacion de Malaga en Biomedicina y Salud | 0,00 € |
| Idener Research & Development AIE | 1.421.625 € |
| Ilmatieteen Laitos | 610.946 € |
| Katholieke Universiteit Leuven | 385.261 € |
| Keydata Bilgi Islem Teknoloji Sistemleri AS | 500.417 € |
| Kneia SL | 373.842 € |
| Luxembourg Institute OF Health | 350.545 € |
| Remote Sensing Solutions GmbH | 422.988 € |
| Servicio Andaluz de Salud | 658.500 € |
| Theramed Healthcare Srl | 274.813 € |
| Trilateral Research Ltd. | 305.000 € |
| Universita Degli Studi Di Milano | 408.146 € |
| Uniwersytet Medyczny w Lodzi | 267.375 € |
Quelle: https://cordis.europa.eu/project/id/101156799
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: European Academy of Allergy and Clinical Immunology, Zürich, Schweiz.